For a consumption based economy to grow, the median family spending money must continue to grow. The disposable income headlines misleadingly infer income is growing.
There are facts, and then there are facts. The headline numbers from the U.S. Census, Bureau of Labor Statistics and Bureau of Economic Analysis are either gross numbers for the entire economy or the gross number divided by the population (per capita). When you view this headline data, either you believe the average person is doing better - or you feel the government is lying because you and everyone around you are worse off.
Chart 1 - Per Capita Real Disposable Income(click to enlarge)
In a consumption based economy, the amount of money in the hands of the consumer is the economic driver. If consumers are flooded with money, often they will buy the best car. If the consumers are poor, they will buy the cheapest car and only when necessary.
Top 10 Companies To Invest In 2015: Sinovac Biotech Ltd.(SVA)
Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against the hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China. It offers Healive, an inactivated hepatitis A vaccine; Bilive, a combination of hepatitis A and B vaccine; Anflu, a split virus influenza vaccine; and Panflu, a vaccine against the influenza A H1N1 virus. The company's pipeline vaccine candidates include a split viron vaccine, which completed Phase II clinical trials for the H5N1 influenza virus; and a SARS vaccine, which completed Phase I clinical trials for the SARS virus. In addition, its pipeline vaccine candidates that completed the pre-clinical trials comprise human vaccines for EV71, pneumococcal conjugate, haemophilus influenzae type b, meningitis, Japanese encephalitis, chickenpox, mumps, and rubella diseases, as well as rabies vaccine for humans and animals. The company markets and sell s its vaccine products directly to the provincial and municipal disease control and prevention centers. It has a patent license agreement with the National Institutes of Health; distribution agreements with LG Life Sciences, Ltd. and Glovax C.V.; and a pandemic influenza vaccine co-development agreement with the China Center for Disease Control and Prevention. Sinovac Biotech Ltd. was founded in 1999 and is headquartered in Beijing, the People's Republic of China.
Advisors' Opinion:- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biopharmaceutical company Sinovac Biotech (NASDAQ: SVA ) has received the dreaded one-star ranking.
- [By Rich Duprey]
Troubling is that it's a new presence in humans, and while that makes its spread among the populace difficult, scientists fear that it's gaining momentum. Sinovac Biotech (NASDAQ: SVA ) , which was approved to produce vaccines several years ago, jumped almost 7% yesterday as it gears up to mass produce a vaccine to combat the new threat.
- [By Louis Navellier]
LGND is a strong buy at today�� price.
Biotech Stocks to Buy: Sinovac Biotech (SVA)Sinovac Biotech LTD (SVA) is a Chinese biotech company that makes drugs to treat conditions such as hepatitis A, hepatitis B, and influenza viruses. The just announced that the phase three trials of a new drug to fight a virus called EV-71 that causes neurological conditions such hand foot and mouth disease showed great promise. Phase III trial results� EV71 vaccine show that the drug had a 94.8% efficacy rate against EV71-related hand, foot, and mouth disease, and a 100% efficacy rate against EV71-associated hospitalization and against HFMD with neurologic complications.
Top Cheapest Companies To Own For 2014: SunCoke Energy Inc (SXC)
SunCoke Energy, Inc. (SunCoke), incorporated on December 8, 2010, is an independent producer of coke, a principal raw material in the integrated steelmaking process. The Company has United States cokemaking operations in Virginia, Indiana, Ohio and Illinois. Outside the United States, SunCoke has cokemaking operations in Vitoria, Brazil and Odisha, India. The Company�� coal mining operations, which have more than 110 million tons of proven and probable reserves, are located in Virginia and West Virginia. In January 2012, SunCoke Energy, Inc. was spun off from Sunoco, Inc.
The Company has designed, developed and built, and owned and operated five cokemaking facilities in the United States (U.S.) and designed and operate one cokemaking facility in Brazil under licensing and operating agreements on behalf of its customer. The cokemaking facility operated in Brazil has cokemaking capacity of approximately 1.7 million tons of coke per year. As of December 31, 2012, its mining area consisted of 13 active underground mines and two active surface and highwall mine in Russell and Buchanan Counties in Virginia and McDowell County, West Virginia. As of December 31, 2012, the Company�� coal mining production was 1.5 million ton.
As of December 31, 2012, the Company owned approximately 66 acres in Vansant (Buchanan County), Virginia, on which the Jewell coke making facility is located, along with an additional 2,550 acres. As of December 31, 2012, the Company owned approximately 250 acres in Russell County, Virginia owned by the HKCC Companies. As of December 31, 2012, the Company owned approximately 400 acres in Franklin Furnace (Scioto County), Ohio. As of December 31, 2012, the Company owned approximately 41 acres in Granite City (Madison County), Illinois, adjacent to the U.S. Steel Granite City Works facility. As of December 31, 2012, the Company owned approximately 250 acres in Middletown (Butler County), Ohio near AK Steel�� Middletown Works facility. The Company leas! ed approximately 88 acres of land located in East Chicago (Lake County), Indiana. As of December 31, 2012, the Company leased approximately 22 acres of land located in Buchanan County, Virginia The Company owns and operates coal mining operations in Virginia and West Virginia that sold approximately 1.3 million tons of metallurgical coal (including internal sales to its cokemaking operations) and 0.2 million tons of thermal coal in 2012. During the year ended December 31, 2012, 69% of the coal the Company sold was used at its Jewell cokemaking facility and 8% was used at its other domestic cokemaking facilities. In addition, through its Jewell coal affiliates and the HKCC Companies, the Company lease small parcels of land, mineral rights and coal mining rights for approximately 127 thousand acres of land in Buchanan and Russell Counties, Virginia and McDowell County, West Virginia.
Advisors' Opinion:- [By Johanna Bennett]
In a note published Friday, Goldman analysts Neil Mehta and Vinit Joshi issued a mix of outlooks for the batter coal sector, among them Buy ratings on CONSOL Energy (CNX) and SunCoke Energy (SXC) and a Sell on Arch Coal (ACI).
Top Cheapest Companies To Own For 2014: BioMarin Pharmaceutical Inc.(BMRN)
BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and rest of the world. The company?s commercial products include Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase enzyme used for the treatment of mucopolysaccharidosis (MPS) VI; Kuvan, a proprietary synthetic oral form of 6R-BH4 used to treat patients with phenylketonuria (PKU), a metabolic disease; Aldurazyme used for the treatment of mucopolysaccharidosis I, a genetic disease; and Firdapse used to treat Lambert Eaton Myasthenic Syndrome, an autoimmune disease. It develops GALNS, an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder; PEG-PAL, an enzyme substitution therapy that is under Phase II clinical trial to treat PKU; BMN-673, a Phase I/II clinical trial product for the treatment of cancer; BMN-701, an enzyme replacement therapy, which is under Phase I/II clinical trials for Pompe disease, a glycogen storage disorder; and BMN-111, a peptide therapeutic that is under Phase I clinical trial for the treatment of achondroplasia. The company sells its Naglazyme, Kuvan, and Firdapse products to specialty pharmacies and end-users, such as hospitals and foreign government agencies, which act as retailers; and Naglazyme products to distributors and pharmaceutical wholesalers. It has a collaboration agreement with Genzyme Corporation for the manufacture of Aldurazyme; and an agreement with Merck Serono S.A. for the further development and commercialization of Kuvan and other products containing 6R-BH4 and PEG-PAL for PKU. BioMarin Pharmaceutical Inc. was founded in 1996 and is headquartered in Novato, California.
Advisors' Opinion:- [By Ben Levisohn]
Somaiya and team named Gilead and�Neurocrine Biosciences (NBIX) their top picks, hile putting Buy ratings on Celgene, Biogen Idec, Alexion (ALXN), Incyte (INCY), Pharmacyclics (PCYC) and Synageva (GEVA). BioMarin (BMRN), Infinity Pharmaceuticals (INFI) and Amgen (AMGN) earned Neutral ratings.
Top Cheapest Companies To Own For 2014: Virgin Australia Holdings Ltd (VBHLF)
Virgin Australia Holdings Limited (VAH) is an Australia-based company engaged in the development and operation of domestic and international airlines. VAH�� fleet includes ATR-72, Embraer 190, Boeing 737-700, Boeing 737-800, AIRBUS A330 and Boeing 777-300ER. It product includes Airbus A330 Business Class. During the fiscal year ended June 30, 2012, the Company carried 19,468,929 guests on 216 city pairs to 52 destinations, and operated 162,817 flights. On February 22, 2012, under the proposal, all of the shares in the international airline business of Virgin Australia were transferred to a new holding company, Virgin Australia International Holdings Pty Ltd. In April 2013, it acquired 100% of the issued share capital in Skywest Airlines Ltd. In July 2013, Virgin Australia Holdings Limited announced that it has acquired 60% interest of Tiger Airways Australia Pty Limited from Tiger Airways Holdings Limited. Advisors' Opinion:- [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- Australian stocks gave ground in early Friday trading, with banks broadly lower after overnight losses in the U.S., where investors worried that better-than-expected data would prompt the Federal Reserve to roll back stimulus soon. The S&P/ASX 200 (AU:XJO) lost 0.4% to 5,178.30, as National Australia Bank Ltd. (AU:NAB) (NAUBF) fell 1.8%, Australia & New Zealand Banking Group (AU:ANZ) (ANEWF) lost 0.8%, and Macquarie Group Ltd. (AU:MQG) (MCQEF) retreated 1.3%. Among the resource shares, losses for gold both in New York and in early Asian electronic trade helped send Evolution Mining Ltd. (AU:EVN) (CAHPF) down 1.9% and Kingsgate Consolidated Ltd. (AU:KCN) (KSKGF) off 4.5%, though Newcrest Mining Ltd. (AU:NCM) (NCMGF) held the drop to 0.4%. Oil prices managed a modest gain, however, resulting in a 0.2% rise for Oil Search Ltd. (AU:OSH) (OISHF) and Karoon Gas Australia Ltd. (AU:KAR) (KRNGF) , while Woodside Petroleum Ltd. (AU:WPL)
No comments:
Post a Comment